Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of RinFast vs NovoRapid in Type 1 Diabetes
NCT04079413Phase 3Completed
- Sponsor
- Geropharm
- Start
- Jun 2019
- Primary completion
- Jan 2020
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 3 trial of insulin aspart biosimilar GP40071 in type 1 diabetes mellitus (T1D), sponsored by Geropharm. Started Jun 2019; status: completed.
02
Drugs
insulin aspart biosimilar GP40071
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04079413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04079413.